Abstract The lung in cystic fibrosis (CF) is home to numerous pathogens that shorten the lives of patients. The aim of the present study was to assess changes in the lung bacteriome following antibiotic therapy targeting Pseudomonas aeruginosa in children with CF. The study included nine children (9-18 years) with CF who were treated for their chronic or intermittent positivity for Pseudomonas aeruginosa. The bacteriomes were determined in 16 pairs of sputa collected at the beginning and at the end of a course of intravenous antibiotic therapy via deep sequencing of the variable region 4 of the 16S rRNA gene, and the total bacterial load and selected specific pathogens were assessed using quantitative real-time PCR. The effect of antipseudomonal antibiotics was observable as a profound decrease in the total 16S rDNA load (p = 0.001) as well as in a broad range of individual taxa including Staphylococcus aureus (p = 0.03) and several members of the Streptococcus mitis group (S. oralis, S. mitis, and S. infantis) (p = 0.003). Improvements in forced expiratory volume (FEV 1 ) were associated with an increase in Granulicatella sp. (p = 0.004), whereas a negative association was noted between the total bacterial load and white blood cell count (p = 0.007). In conclusion, the data show how microbial communities differ in reaction to antipseudomonal treatment, suggesting that certain rare species may be associated with clinical parameters. Our work also demonstrates the utility of absolute quantification of bacterial load in addition to the 16S rDNA profiling.
Introduction
Cystic fibrosis (CF) is caused by mutations in the gene for cystic fibrosis transmembrane conductase regulator (CFTR) protein which, among other effects, causes impairments in mucociliary clearance. This enables bacteria to become established in the lungs, which leads to a decline in pulmonary function and ultimately to respiratory failure. One of the most important CF pathogens is Pseudomonas aeruginosa. This species often dominates the CF lung bacteriome not only in adults (Cox et al. 2010; Hauser et al. 2011 ) but also in a considerable number of children (Hauser et al. 2011; Li et al. 2005; Pillarisetti et al. 2011) . Once present in the lower airways, it can cause chronic infections that are difficult to treat (Doring and Hoiby 2004) . However, antibiotic treatment of patients with chronic P. aeruginosa infection occasionally improves the patient's health status, including their lung function, despite the fact that the quantity of the pathogen in the lower airways remains seemingly unchanged (Price et al. 2013; Zemanick et al. 2013 ). Pulmonary exacerbations in CF patients are not solely dependent on the presence of P. aeruginosa in the lung (Zemanick et al. 2010) . Therefore, interest has expanded toward other species that may cohabit Electronic supplementary material The online version of this article (https://doi.org/10.1007/s12223-017-0562-3) contains supplementary material, which is available to authorized users. the lower airways and play either beneficial or harmful roles in the development of the CF lung disease (Zemanick et al. 2011 ). This area is especially important with respect to the lung bacteriome during childhood, which is believed to be amenable to changes (Coburn et al. 2015; Li et al. 2005) .
Our study aimed to investigate changes in the lung bacteriome in patients with chronic or intermittent P. aeruginosa infection in relation to intravenous antibiotic treatment. The novel aspect of the study design was a combination of 16S rDNA profiling with a set of species-specific PCR reactions that allowed us to measure changes in the absolute quantity of several bacterial species other than P. aeruginosa.
Material and methods

Subjects
All study subjects attended the CF Centre at the Motol University Hospital, Prague, the Czech Republic; this center takes care of more than 200 children and young persons with the disease. The main inclusion criterion for the patients was an intermittent or chronic infection by P. aeruginosa (intermittent infections were characterized by less than 50% positive samples for P. aeruginosa over the last 12 months, while chronic infections were defined with more than 50% of samples for P. aeruginosa over the last 12 months, as per Leeds criteria (Lee et al. 2003) ).
We recruited nine patients (seven females) aged from 9 to 18 years (median age 14.5 years): two of them (one female) having intermittent P. aeruginosa infection and the remaining seven having chronic infection. The patients had a combined total of 16 courses of antibiotic therapy with a combination of intravenous antibiotics. Seven of the courses were indicated for pulmonary exacerbation, while nine were prescribed as part of chronic suppressive antipseudomonal therapy. Virtually every patient received a different cocktail of two or more antibiotics with the aim to control their P. aeruginosa infection. The choice of antibiotics (Supplementary Table S1 ) was based not only on susceptibility test results of the most recent P. aeruginosa isolate (Supplementary Table S2 , Supplementary material S1.1) but also on drug toxicity, tolerability, and clinical benefit observed upon their previous use (Doring et al. 2012) . Patient records of inflammatory markers [white blood cell (WBC) count, C-reactive protein (CRP)] and forced expiratory volume (FEV 1 ) were also collected (Table S1 ). The study was run between September 2012 and November 2013. A written consent was obtained from all patients or their guardians, and the study was approved by the institutional Ethics Committee, University Hospital Motol, Prague on September 19, 2012, EK-1445/12.
Sputum samples
Spontaneously expectorated sputum was collected on the day when antibiotic therapy started and on the last day of antibiotic treatment, hereinafter referred to as Bbefore^and Bafter^anti-biotic therapy. The courses of antibiotic therapy lasted from 11 to 21 days (median 13.5 days). Three patients provided a single pair of samples covering one course of antibiotic therapy, five patients underwent two courses, and one patient had three courses of the therapy. The time interval between multiple applications of intravenous antibiotics ranged from 79 to 212 days (median 120 days). We analyzed a total of 32 samples, and they were also investigated by routine culture-based microbiological methods and microscopically validated as lower airway samples.
DNA extraction
An aliquot of sputum was frozen immediately upon expectoration. When thawed, it was liquefied with a mixture of saline with 46 mmol/L KH 2 PO 4 , 32 mmol/L NaOH, and 0.9 mg/mL acetylcysteine (Hexal AG, Holzkirchen, Germany) and centrifuged. The bacterial pellet was pretreated by incubation with 50 μg lysostaphin (Sigma-Aldrich, St. Louis, MO, USA) for 1 h at 37°C, followed by incubation with proteinase K; DNA was then extracted using a QIAamp DNA kit (Qiagen, Hilden, Germany). The extraction efficiency was checked by adding a plasmid containing a fragment of Arabidopsis thaliana DNA as an exogenous internal control that was then quantified using a specific PCR reaction; this control was not intended for normalizing for the sputum content.
Deep sequencing profiling of the 16S rDNA and data processing
Deep sequencing to identify the content and structure of bacterial community targeted the V4 region of the 16S rRNA gene and was performed on a MiSeq sequencer with a 2 × 250-bp sequencing kit (Illumina, San Diego, CA, USA). Data were processed using the tools QIIME (Caporaso et al. 2010) and Mothur (Schloss et al. 2009 ). The process is described in detail in Supplementary material, S2.1 and S2.2. To control the sequencing process and subsequent analysis steps, an artificial mock community was sequenced along with the samples (courtesy of BEI Resources, NIAID, NIH; Genomic DNA from Microbial Mock Community B -Even, Low Concentration -v5.1L, for 16S rRNA Gene Sequencing, HM-782D). All samples including the mock community and negative controls were sequenced in triplicate, with each replicate prepared in a separate PCR plate.
Conversion of data from 16S rDNA relative quantity to absolute quantities and specific PCR For analyses based on relative quantity, OTUs were clustered based on 97% similarity and filtered for being present in at least 5% of samples by at least 50 reads. The dominant pathogen in each sample was defined as the one exceeding by at least two times the relative abundance of the second most abundant taxon (Carmody et al. 2013; Coburn et al. 2015) .
Species richness and evenness was compared using Shannon index between groups of samples from patients positive and negative for markers of inflammation: the upper normal limits were 13 × 10 9 /L WBC and 8 mg/L CRP. The effect of antibiotic treatment on the total bacterial load and on absolute concentrations of abundant taxa was assessed using the Wilcoxon-paired test with the Bonferroni adjustment for multiple comparisons, and the associations with clinical outcomes (FEV 1 % predicted, WBC count, CRP) were assessed using generalized estimating equations in models which accounted for the repeated character of measurements. Analyses were performed using R package version 3. 
Results
To analyze both the overall bacteriome composition and the quantity of its most abundant individual species, we exploited features of two different molecular approaches. While the taxa identification with their relative abundance was obtained by the 16S rDNA profiling using next generation sequencing (NGS), the absolute quantity of selected taxa was determined by using either a species-specific RQ-PCR [P. aeruginosa, S. aureus, H. influenzae, and part of the Streptococcus mitis group (S. oralis, S. mitis, S. infantis)], or for less traditional CF-related pathogens, a product of relative abundance from 16S rDNA profiling with quantity from 16S rDNA panbacterial RQ-PCR. The results obtained by both approaches are summarized in Fig. 1a-d .
Bacterial taxa change upon antibiotic therapy in both absolute and relative quantities
The 16S rDNA triplicates of each sample were inspected for consistency using clustering graphs and merged, yielding between 48,641 and 194,050 sequences per sample (interquartile range 25,179-38,663; median 29,206) . The total number of 824 OTUs was generated, many of them belonging to wellknown CF pathogens, such as Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans. The first 11 taxa ranked by overall relative abundance are listed in Table 1 , where their quantities are compared before and after the therapy. S. aureus was the most abundant pathogen in our samples, followed by P. aeruginosa. The effect of antipseudomonal antibiotics on the relative 16S rDNA profiles as well as on absolute quantities was significant yet heterogeneous among individual taxa (Fig. 2 , Supplemental Fig. S1 ). We noted a substantial decrease in the total bacterial load following antibiotic therapy (p = 0.001, Fig. 1c ); this decrease was most profound in the samples where S. aureus or P. aeruginosa dominated (Fig. 3) .
The absolute quantity of S. aureus measured by speciesspecific PCR showed a constant and significant decrease ( Fig.  2 , P corrected = 0.03) and responded well to antipseudomonal treatment with post-antibiotic quantities that were often undetectable. The 16S rDNA profiling showed that S. aureus was dominant in pre-antibiotic samples from five courses of antibiotic therapy but remained the most abundant only in two of them following antibiotic therapy (Fig. 2a) , again indicating a profound response to antibiotic treatment. However, in two post-antibiotic samples (P4 course 2, P8 course 2), 16S rDNA profiling showed an increase in relative abundance of Staphylococcus spp. (comprising S. aureus, S. epidermidis, and S. hominis), while species-specific PCR targeting only S. aureus was negative (Fig. 2a) . This implies that S. epidermidis and/or S. hominis were responsible for this increase, as the V4 region of the 16S rRNA gene is identical for the three species, and they cannot be distinguished by the NGS method alone.
P. aeruginosa was ranked second in quantity after S. aureus and was detected in eight courses of antibiotic therapy by NGS and in 11 courses by species-specific PCR (Fig. 2b) . P. aeruginosa dominated the lung bacteriome in three of eight Pseudomonas-positive pre-antibiotic samples and in three of seven post-antibiotic samples ( 
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Course of antibiotic therapy susceptible to antibiotics with a decrease in its absolute quantity in most cases (7 of 11 courses, Fig. 2b ). However, overall changes in P. aeruginosa quantity seemed to be dependent on its proportion in the bacteriome: two courses of antibiotic therapy (P7 course 2, P9 course 1) in patients, whose samples were not dominated by P. aeruginosa, resulted in almost no change in its absolute quantity after antibiotic treatment. Furthermore, in two courses (P2 course 2, P6 course 1) both the absolute and relative quantities of P. aeruginosa significantly increased despite the fact that in vitro antibiotic susceptibility tests showed that it was susceptible to the antibiotics used (Table S2) . In both cases, P. aeruginosa was not a dominant species in the pre-antibiotic sample. In addition to P. aeruginosa and S. aureus, other traditional CF pathogens were also found in the pre-antibiotic samples. H. influenzae and A. xylosoxidans were both dominant in the pre-antibiotic samples (Fig. 3, Fig. S1C ), and both responded well to antipseudomonal treatment (P c o r r e c t e d for H. influenzae = 0.055). By contrast, S. maltophilia was dominant only after antibiotic therapy and the increase with therapy was observed also in absolute numbers (Fig. 1b) . Several members of the Streptococcus mitis group (S. oralis, S. mitis, and S. infantis) detected by group-specific real-time PCR also showed a significant and consistent absolute decrease with antibiotic treatment (P corrected = 0.003) (Fig. S1D) .
Exploration of alpha diversity
Antibiotic therapy for pulmonary exacerbations was borderline-associated with a decrease in the complexity of the lung bacteriome ( Supplementary Fig. S2 A) . This tendency toward the decrease in diversity was indicated by some alpha (within-sample) diversity indices (observed species, praw = 0.03; Chao1, p raw = 0.05; and ACE, p raw = 0.03; Fisher, p raw = 0.022; paired t test), but in contrast, the Shannon and Simpson diversity indices, often used for their ability to also distinguish the evenness of the species distribution, did not appreciably change (p raw = 0.89, p raw = 0.74, respectively).
Association with clinical markers and with the dominant pathogens
Species richness measured by Shannon index had a borderlinesignificant tendency toward inverse association with CRP, but not with increased leukocytes (Supplemental Fig. S2 B) . A significantly lower Shannon index was found in samples with dominant pathogens among the Btraditional^CF-related bacteria (P. aeruginosa, S. aureus, A. xylosoxidans, H. influenzae, S. maltophilia), p < 10 −5 when compared to samples without a dominant species, or with samples dominated by other organisms. The Shannon index also decreased with decreasing values of FEV 1 %, p = 0.003 (Supplemental Fig. S2 B) . We then tested the association of the 11 most abundant taxa (Table 1 ) with a change in markers of clinical improvement. The 11 taxa were chosen based on their presence as a dominant pathogen or based on their average relative abundance in all samples higher than 5%. The following clinical parameters were tested: FEV 1 % predicted, as a parameter of lung function, and WBC count and CRP, as markers of inflammation. An association with improvement of lung function was found for Granulicatella sp. (present in five pre-antibiotic samples and six post-antibiotic samples); in the regression model, a ten-fold increase in its quantity was associated with an increase in the FEV 1 of 5.5% (p = 0.004). We also detected a significant association of the total bacterial load with the WBC count; a ten-fold decrease in the total 16S rDNA load was associated with a decrease in WBCs by 2 × 10 9 /L (p = 0.007). No associations with CRP levels were noted.
Correlation between specific PCR detection and 16S rDNA profiling
To assess the accuracy of calculated absolute quantities (obtained by the conversion of the taxon proportion from the NGS 16S rDNA profile, multiplied by the total 16S rDNA load from generic real-time PCR), these values were directly compared to quantities from species-specific real-time PCR. The comparison for P. aeruginosa is illustrated in Supplementary Fig. S6 . Although the overall results acceptably correlate (R = 0.92, p < 10
; Spearman rank correlation test), a discrepancy can be noted in samples found negative by specific PCR: here the 16S rDNA NGS profiling reports a low, but positive signal. Similar to P. aeruginosa, in Fig. 1 a-d The effect of antibiotic treatment on the composition of the lung bacteriome. A sample after a course of antibiotic therapy was compared to its paired sample before therapy. Changes in the sputum bacteriome were assessed by three methods. a The relative 16S rDNA profiles are used for calculations of the fold changes, disregarding the overall quantity of bacteria in the sputum sample. b The fold changes are calculated from absolute quantities of each taxa, which were derived from the proportion of the taxon within the 16S rDNA profile multiplied by the absolute concentration of all bacteria in microliters of sputum, as determined using real-time PCR. c The total bacterial 16S rDNA concentration, assessed using real-time PCR with generic primers in pre-antibiotic sample (red circle) and its corresponding post-antibiotic sample (blue circle). The arrow shows the direction and magnitude of response. d Fold change in the total bacterial concentration between the paired sputum samples taken before and after the antibiotic therapy. Identical data as in c, presented in relative scale. a, b The 16 taxa with the highest relative abundance in the overall sputum bacteriome; the last, E. coli, is a product of bacterial contamination of the polymerase utilized for 16S rDNA amplification (Spangler et al. 2009 ). The color codes show the decadic logarithm of the relative change between the paired samples before and after the antibiotic treatment (blue for a decrease with treatment, red for an increase with treatment, white for no appreciable difference). Rows: individual bacterial taxa, ordered by the average relative share in sputum. Columns: individual episodes = courses of antibiotic therapy, coded by numeric identification of the patient, and the sequential identification of the course Species present in the sample by at least 1% of relative abundance e Dominance is defined as being at least 2× more abundant than the second most abundant species (Carmody et al. 2013; Coburn et al. 2015) S. aureus and H. influenzae, the absolute quantities obtained by PCR and NGS correlate generally well (p < 10 −6 , Spearman rank correlation test), but NGS yielded several false-positive samples.
Relative and absolute quantification
Presented results were obtained by using two different approaches, the relative quantity resulting from 16S sequencing and absolute quantity obtained by either species-specific PCR or by a conversion of 16S results with the total 16S load. Inspecting the same pairs of sputum samples, the results by both approaches differed, as illustrated in Fig. 2 : in two antibiotic courses, species-specific PCR reported a decrease in quantity of P. aeruginosa while an increase in relative quantity was reported by 16S sequencing (courses P2c1, P9c1). Similar inconsistency was noted for S. aureus (course P9c1, courses P4c2 and P8c2 reported an increase of relative abundance of S. epidermidis/hominis) and for other species (data not shown).
Contaminating signals
The analysis of multiple negative controls indicated that the signal of E. coli most likely originated from PCR chemicals rather than from the sputum itself ( Supplementary Fig. S3 ). The signal of Escherichia coli, which was found in all samples in average proportion of 2.4%, also seemed to change with the antibiotic therapy: it consistently increased in relative quantity in all post-antibiotic sputum samples ( Supplementary Figs. S4 A, S5). After a conversion of E. coli 16S profiles to absolute quantity values by multiplication with the total 16S load, an actual decrease of quantity was noted in nine courses of antibiotic therapy ( Supplementary Figs. S4 B) and the change in E. coli absolute quantity seemed to inversely copy the change in absolute bacterial concentration ( Supplementary Figs. S5,  S4C ). While the specific detection shows a good response to antibiotic treatment, the 16S rDNA sequencing (lower panel) in antibiotic courses P4c2 and P8c2 documents an increase in the proportion of reads: the V4 region of the rDNA gene does not allow distinguishing S. aureus from S. epidermidis and S. hominis, this signal therefore comes from either of the latter two species. b P. aeruginosa and its changes over the courses of antibiotic treatment. Species-specific PCR had a lower detection threshold than 16S rDNA sequencing
Discussion
Our study assessed the lung bacteriome profiles in sputum samples from pediatric patients chronically or intermittently infected with P. aeruginosa. Samples were taken at the beginning and at the end of intravenous antibiotic treatment either as a part of maintenance treatment or for treating an acute exacerbation. Both the total bacterial load and the composition of the sputum 16S rDNA profile changed in all sputum pairs. Apart from detection of changes in the bacteriome, we also compared different methods used for studying lung microbes. The total bacterial load, measured by quantitative real-time PCR of the 16S rDNA, significantly decreased following antibiotic therapy; this decrease was as great as four orders of magnitude over 2 weeks and was significantly associated with a decrease in WBCs. However, the total bacterial load change was not associated with changes in lung function (FEV 1 %), which can be explained by the degree of diversity among individual lung microbiota that contained species ranging from obligate CF pathogens to bacteria potentially beneficial to CF patients. The rapid and profound response of the total bacterial load to the i.v. therapy may indicate plasticity of pediatric lung bacteriome; this observation is in contrast to data published in adults (Price et al. 2013; Zemanick et al. 2013) .
Diversity indices enabled us to observe the complexity of the bacteriome. The most important driver of alpha (withinsample) diversity was the dominant pathogen, as has been reported by previous studies (Carmody et al. 2015; Coburn et al. 2015; Filkins et al. 2012) . Communities dominated by streptococci were associated with significantly higher diversity than those dominated by Pseudomonas or Staphylococcus. Furthermore, Streptococcus-driven communities are also known to be very stable not only during periods of clinical stability but also during periods of exacerbation (Carmody et al. 2015) , which was true, e.g., for all three courses of antibiotic therapy experienced by patient 5 (Fig. 3) .
Interestingly, higher species richness was associated with better clinical status, as measured by FEV 1 and marginally also by CRP as a marker of inflammation. A similar association was observed in other studies (Coburn et al. 2015; Fodor et al. 2012; van der Gast et al. 2014; Zhao et al. 2012) . We believe that the richer species distribution in such communities (which are devoid of classical CF pathogens) can better mimic the transient polymicrobial nature of healthy lungs and Fig. 3 Changes in relative abundance of the top 11 taxa assessed by NGS. Each pair of bars represents one course of antibiotic therapy; the first bar represents a sample taken at the beginning of antibiotic therapy (referred to as Bbefore^) and the second is taken at the end of the therapy (referred to as Bafter^). Patient and the course of antibiotic treatment are identified at the top of the bar. Each color represents the fraction of one of the top 11 OTUs. These 11 were selected because of their presence as a dominant pathogen in any of the samples or if their average relative abundance exceeded 5%. Several OTUs were identified only as a group of taxa that could not be distinguished by the V4 region of the 16S rRNA gene-therefore potential species of this OTU are listed. The sum of remaining OTUs is shown in light blue, and they fill each bar up to 100%
can be a marker of less severe lung disease in CF patients, as previously described (Zhao et al. 2012) . Alpha diversity indices of observed species, Chao1, and ACE significantly decreased with therapy, whereas the Shannon and Simpson indices did not. The latter two represent richness as well as evenness, and their usage has been encouraged by other studies (Carmody et al. 2013 (Carmody et al. , 2015 Price et al. 2013; Zemanick et al. 2013) .
A considerable response to antipseudomonal therapy was noted for all detected CF-related pathogens, such as P. aeruginosa, S. aureus, H. influenzae, and A. xylosoxidans, confirming that antipseudomonal treatment was effective against a broad spectrum of pathogens. In two instances (courses P2c2 and P6c1), other pathogens (H. influenzae, S. aureus) were profoundly reduced, whereas P. aeruginosa increased both in relative proportion and absolute numbers despite its in vitro sensitivity to the administered antibiotics. The reason for this is not at hand-heterogeneity of P. aeruginosa strains which co-exist in the lungs probably plays a role (Winstanley et al. 2016) . A similar relative increase of the bacterium during antipseudomonal therapy was reported by Daniels et al. (2013) using a T-RFLP method; however, the authors reported no absolute bacterial quantities; therefore, their results are difficult to compare to the present observations.
Apart from these commonly detected pathogens, we observed a number of species that are less often regarded to be part of traditional CF microbiology, especially anaerobes. These species are becoming a focus of research for their relatively frequent occurrence as dominant pathogens (Carmody et al. 2015; Price et al. 2013) even at the time of pulmonary exacerbations (Zemanick et al. 2010) when the 16S rDNA profiling of CF respiratory samples is applied. Proving causative links has been extremely complicated because of their concurrent occurrence in the upper airways (Goddard et al. 2012 ) and the lack of routine culture-based results. Interestingly, the species-specific PCR showed that several members of the Streptococcus mitis group (S. oralis, S. mitis, and S. infantis) significantly decreased in quantity upon antibiotic therapy. Streptococci found in the sputum samples have also been often identified in oral flora (Filkins et al. 2012) , which complicates our understanding of their role in CF lungs, as they might originate from the upper airways. This effect is especially true for children because of their limited ability to expectorate sputum. However, many studies support the presence of streptococci and other non-CFrelated species in lower airways and their potential role in CF lung disease, as reviewed by Caverly et al. (2015) .
At present, we have no plausible explanation for the positive association of Granulicatella spp. with increased FEV 1 . The genus Granulicatella was established in 2000 and previously belonged to nutritionally variant streptococci (Cargill et al. 2012) . The genus is a component of the normal oral microflora, similar to the viridans streptococci that were also found in CF lungs (Cargill et al. 2012; Filkins et al. 2012) . The genetic relatedness of Granulicatella to these streptococci can also be indicative of its association with better lung function, similar to what was observed for streptococci (Filkins et al. 2012) . To the best of our knowledge, no association between clinical status and Granulicatella has been described, so the finding merits further investigation. Indeed, relationships similar to what we detected, especially for non-CF-related pathogens, are known from the literature, but no consistent conclusions can be drawn (Carmody et al. 2013; Zemanick et al. 2013) . Interestingly, Granulicatella adiacens was found to be associated with lung cancer (Cameron et al. 2017) , which may further support its utility as a marker organism in various processes.
One strength of our study is the focus on children, an age group often underrepresented in the literature regarding the lung bacteriome. Similar to other authors, we believe that bacteriome features are different in children compared to adult patients. A study by van der Gast et al. (2014) that included children and adults with different chronic lung diseases revealed a high degree of clustering within the pediatric cohorts; however, the adults clustered neither within the adult cohort nor with their pediatric counterparts. Interestingly, the most common species detected in pediatric patient cohorts were also found in four healthy children included in that study. Children and adults are also reported to differ with regard to species richness; higher species richness is associated with better lung function in children (Coburn et al. 2015; van der Gast et al. 2014) . Antibiotic treatment for pulmonary exacerbation represents the key factor for species turnover, as described previously (Cuthbertson et al. 2015) , and is therefore an important variable in shaping the lung bacteriome.
A second strength of our study is that we determined both relative and absolute quantities of bacterial species. 16S rDNA profiling, which confers the information about relative quantity only, was utilized for identification of taxa and to determine their fraction in the bacteriome. However, the real effect of antibiotics on bacterial mass cannot be revealed unless absolute quantities are also known. The situation is exemplified in Fig. 1 , where an increase of relative proportion of bacteria was noted while the Btrue^absolute quantity reported a decrease in several instances. Although most studies describe bacterial lung communities by relative abundance (Coburn et al. 2015; Cuthbertson et al. 2015; van der Gast et al. 2014) , few have also evaluated the absolute quantity (Carmody et al. 2015; Zemanick et al. 2013) . We used specific real-time PCR to quantify not only the overall bacterial load but also the four most important groups of CF pathogens. The use of absolute quantities also helps resolve the weak contamination of PCR polymerases by bacterial DNA. It is known that some recombinant polymerases are weakly contaminated by E. coli 16S rDNA or other bacterial DNA (Spangler et al. 2009 ). This contamination emerges in the bacteriome profiles only if there is little bacterial DNA in the sample; the contaminant proportion, therefore, logically increases in postantibiotic samples (Fig. S4) .
The use of two methodological approaches also revealed the difference in the true detection thresholds and specificity: species-specific PCR performed better than NGS 16S profiling. The NGS profiling produces several false low-positive signal, probably caused by a signal cross-bleed among samples. This is a known phenomenon caused by imperfection in the currently available sample indexing strategy and has been reported by others and us (Kircher et al. 2012; Kramna et al. 2015) . Furthermore, low abundance bacteria may be diminished in the 16S profiles-more abundant species are amplified preferentially as compared to species present in low quantities (Gonzalez et al. 2012) .
Among the limitations, we do not know whether we detected predominantly live bacteria, or also leftovers of DNA from dead cells. Detecting DNA from dead bacterial cells may lead to underestimation of the antibiotic effect on taxa, as reported by Rogers et al. (2010) . Given that the dynamics of bacteriome profile changes were extreme (several orders of magnitude quantity changes), we believe that the majority of the signal came from live organisms. Secondly, the use of chemicals such as propidium monoazide (PMA) enables one to block the dead cell signal; however, numerous other issues connected with the use of PMA may act as a source of bias, as reviewed in Caverly et al. (2015) . The quantitative PCR efficacy may also marginally differ among species, as the bacteria do not have equal copy numbers of the 16S rRNA genes, and primers themselves may also vary in efficacy; the assessment of calibration curves, however, suggested that this source of variation is not prominent. Furthermore, we used lysostaphin, but no other enzymes in the DNA extraction protocol. Rather than the sole use of lysostaphin, it seems that the present protocols tend toward enzyme cocktails, although their composition has not been agreed upon universally (Bera et al. 2005) . A cocktail of enzymes might have further improved the lysis of bacterial walls (Bag et al. 2016; Yuan et al. 2012) .
Furthermore, the use of the sole V4 region was not be able to distinguish among certain groups of pathogens, such as for staphylococci: S. aureus, S. epidermidis, and S. hominis. While S. aureus is a known pathogen, the other two have been reported as commensals on the skin (Otto 2009; Weinstein et al. 1998 ) and have not normally been linked with a lung condition. Most of the time, they appear as sample contaminants (Otto 2009; Weinstein et al. 1998) , so the presently available data cannot resolve whether the increase in their quantity observed in treatment courses P4c2 and P8c2 is genuine or not.
Finally, our data have limited generalizability, primarily because of the limited patient sample size, frequency of sampling, and a gender imbalance. It was previously reported that females are more prone to a progression of pseudomonal infection than males (Chotirmall et al. 2012) . We also did not take into account the fact that the virulence of individual taxa likely changes when crossing a certain quorum (Ulrich et al. 2010) . At last, our results monitor only the period of antibiotic treatment and we do not know what happened later during the recovery, as studied elsewhere (Cuthbertson et al. 2015; Price et al. 2013 ).
In conclusion, our study exemplifies the heterogeneity of changes in the composition of the pediatric lung bacteriome following intravenous therapy for chronic or intermittent infection with P. aeruginosa. This study supports the use of absolute bacterial counts derived from the combination of total bacterial load quantification by real-time PCR and 16S rDNA profiling using next generation sequencing. Finally, we observed a possible novel association of Granulicatella sp. with an improvement in lung function.
